NOTICES: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel,
Published: 2008-06-18
Special Emphasis Panel (SEP): Epidemiological Studies of
Reproductive and Developmental Outcomes in Denmark: Supplement on
Congenital Cytomegalovirus Infection among Children with Hearing Loss, Program Announcement Number (PA) DD 07001
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Centers for
NOTICES: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel,
Published: 2008-06-18
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Times and Dates: 9 a.m.5:30 p.m., July 9, 2008 (Closed); 9 a.m.1 p.m., July 10, 2008 (Closed).
Place: Hyatt Regency Atlanta, 265 Peachtree Street, NE.,
NOTICES: National Center for Injury Prevention and Control/Initial Review Group,
Published: 2008-06-18
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned review group:
Name: National Center for Injury Prevention and Control/Initial Review Group, (NCIPC/IRG).
Time and Date: 11 a.m.12 noon, July
NOTICES: Modification of NIOSH Standard for a Chemical, Biological, Radiological, and Nuclear Full Facepiece Air-Purifying Respirator,
Published: 2008-06-18
The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces the opportunity for manufacturers and stakeholders to provide
NIOSH with input on the potential modification of the NIOSH Statement
of Standard for a Chemical, Biological, Radiological, and Nuclear
(CBRN) Full
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-06-18
Proposed Projects
Title: Generic Clearance to Conduct Qualitative Data Collections.
OMB No.: New Collection.
Description: The Office of Planning, Research and Evaluation
(OPRE), Administration for Children and Families (ACF), U.S. Department
of Health and Human Services (HHS), intends to request approval from
the Office of Management and
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-06-18
Proposed Project
Title: Communities Empowering Youth Evaluation Study.
OMB No. New Collection.
Description: The information collection activity proposed under
this notice will obtain information about lead and partner
organizations funded under the Communities Empowering Youth (CEY)
program. The information collected will complement a
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-06-18
Proposed Projects
Title: Continued Tracking of Families in the Head Start Impact Study.
OMB No.: 09700229.
Description: The Administration for Children and Families (ACF) of
the Department of Health and Human Services (HHS) plans to collect
followup information from children and families in the Head Start
Impact Study (OMB No.
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-06-18
Proposed Project
Title: Early Head Start Family and Child Experiences Survey (Baby FACES).
OMB No. New Collection
Description: The Administration for Children and Families (ACF),
U.S. Department of Health and Human Services, is conducting a
descriptive study of Early Head Start Programs (Early Head Start Family
and Child Experiences
NOTICES: Agency Information Collection Activities; Proposals, Submissions, and Approvals,
Published: 2008-06-18
OMB No.: 09700155.
Description: The Program Instruction, prepared in response to the
enactment of the CommunityBased Grants for the Prevention of Child
Abuse and Neglect (administratively known as the Community Based Child
Abuse Prevention Program, (CECAP), as set forth in Title II of Pub. L.
108 36, Child Abuse Prevention and Treatment Act
NOTICES: Government-Owned Inventions; Availability for Licensing,
Published: 2008-06-18
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: Government-Owned Inventions; Availability for Licensing,
Published: 2008-06-18
The inventions listed below are owned by an agency of the U.S.
Government and are available for licensing in the U.S. in accordance
with 35 U.S.C. 207 to achieve expeditious commercialization of results
of federallyfunded research and development. Foreign patent
applications are filed on selected inventions to extend market coverage
for companies
NOTICES: Center for Scientific Review,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Center for Complementary and Alternative Medicine,
Published: 2008-06-18
The National Center for Complementary and Alternative Medicine
(NCCAM) will convene a workshop on Meditation for Health Purposes. The
goals of the workshop are to assess current knowledge and identify
opportunities for future research on the mechanisms and efficacy of
meditation practices for a variety of health concerns. This workshop
will bring
NOTICES: National Heart, Lung, and Blood Institute,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Institute of Allergy and Infectious Diseases,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Arthritis and Musculoskeletal and Skin Diseases,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Institute of Child Health and Human Development,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Dental and Craniofacial Research,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of Diabetes and Digestive and Kidney Diseases,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: National Institute of General Medical Sciences,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Institute of Mental Health,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Institute on Aging,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: National Institute on Drug Abuse,
Published: 2008-06-18
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the
NOTICES: Geldanamycin Derivative and Method of Treating Viral Infections,
Published: 2008-06-18
This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37
CFR Part 404.7(a)(1)(i), that the National Institutes of Health,
Department of Health and Human Services, is contemplating the grant of
an exclusive patent license to practice the invention embodied in U.S.
Patent No. 6,890,917, issued May 10, 2005, entitled ``Geldanamycin
Derivative